The recent Rosen et al. study in NTRK fusion-positive cancers reported no co-occurrence with KRAS, NRAS, BRAF, EGFR, ALK, MET or ROS16, and we did not observe co-occurrence with these genes either. This evidence concerns the gene MET and cancer.